Foundation Fighting Blindness

Foundation Fighting Blindness

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.

  1. 28 ENE

    Opus Genetics Receives Funding for Gene Therapy Clinical Trial for MERTK-Related RP

    Marking an important milestone for this rare form of retinitis pigmentosa (RP)

    2 min

  2. 16 ENE

    AAVantgarde Completes Enrollment in Retinal Gene Therapy Trial for Usher Syndrome Type 1B

    Milestone brings hope to patients with rare inherited retinal disease

    2 min

  3. 13 ENE

    SpliceBio Begins Dose-Expansion Phase of Clinical Trial for Stargardt Disease Protein Splicing Therapy

    First patient treated in Part B of ASTRA trial evaluating SB-007.

    3 min
  4. Eye on the Cure Podcast | Episode 98: Jonathan & Josh Steinberg

    9 ENE

    Eye on the Cure Podcast | Episode 98: Jonathan & Josh Steinberg

    Josh Steinberg and his father, Jon, talk with host Ben Shaberman about their close-knit family's journey with Josh's vision loss and eventual diagnosis of retinitis pigmentosa, as well as their volunteer leadership roles in driving the Foundation's mission. Jon is Chair of the Foundation's Science Committee and Vice Chair for Science on the Board. Josh is the former Chair of the Strategic Council and also a Board director.

    47 min
  5. Eye on the Cure Podcast | Episode 97: Lindsey Rambo

    19/12/2025

    Eye on the Cure Podcast | Episode 97: Lindsey Rambo

    Lindsey Rambo, a special education teaching assistant, mom, and wife, talks to host Ben Shaberman about her journey with Leber congenital amaurosis 5 (LCA5), participation in Opus Genetics' LCA5 gene therapy clinical trial, and her appearance on Good Morning America to tell her story about meaningful vision improvements.

    40 min

  6. 18/12/2025

    Beacon Therapeutics Launches Clinical Trial for Bilateral Administration of XLRP Gene Therapy

    The company has also fully enrolled the Phase 2/3 VISTA clinical trial for its XLRP gene therapy.

    2 min
  7. Eye on the Cure Podcast | Episode 96: Dr. Deniz Dalkara

    05/12/2025

    Eye on the Cure Podcast | Episode 96: Dr. Deniz Dalkara

    Dr. Deniz Dalkara, a research director at INSERM in France, talks to hose Ben Shaberman about her emerging gene-agnostic, gene therapy designed to restore cone-mediated vision in people with advanced retinitis pigmentosa. Known as SPVN20 and clinically developed by SparingVision, the treatment recently moved into a clinical trial in Europe. Dr. Dakara also discusses her earlier work in retinal gene and optogenetic therapy development.

    44 min

  8. 02/12/2025

    Belite Bio to Seek FDA Approval for its Stargardt Disease Drug

    Tinlarebant slowed disease progression by 36 percent in the Dragon Phase 3 clinical trial.

    3 min
Ver todo (246)

Acerca de

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.

Información

  • Creador
    Foundation Fighting Blindness
  • Años de actividad
    2021 - 2026
  • Episodios
    246
  • Clasificación
    Apto
  • Copyright
    © All rights reserved
  • Mostrar sitio web
    Foundation Fighting Blindness

También te podría interesar